{"id":"https://openalex.org/W1982990258","doi":"https://doi.org/10.1097/01.aids.0000226953.56976.ad","title":"Atazanavir and lopinavir/ritonavir: pharmacokinetics, safety and efficacy of a promising double-boosted protease inhibitor regimen","display_name":"Atazanavir and lopinavir/ritonavir: pharmacokinetics, safety and efficacy of a promising double-boosted protease inhibitor regimen","publication_year":2006,"publication_date":"2006-05-11","ids":{"openalex":"https://openalex.org/W1982990258","doi":"https://doi.org/10.1097/01.aids.0000226953.56976.ad","mag":"1982990258","pmid":"https://pubmed.ncbi.nlm.nih.gov/16691064"},"language":"en","primary_location":{"id":"doi:10.1097/01.aids.0000226953.56976.ad","doi":"https://doi.org/10.1097/01.aids.0000226953.56976.ad","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.aids.0000226953.56976.ad","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001003748","display_name":"Esteban Ribera","orcid":"https://orcid.org/0000-0002-3752-8808","observed_orcids":["https://orcid.org/0000-0002-3752-8808"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Esteban Ribera","raw_affiliation_strings":["Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Paseo Vall Hebron 119-129, 08035 Barcelona, Spain. eribera@vhebron.net","Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Paseo Vall Hebron 119-129, 08035 Barcelona, Spain. eribera@vhebron.net","institution_ids":["https://openalex.org/I4210127641"]},{"raw_affiliation_string":"Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047354915","display_name":"Carlos Azuaje","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Carlos Azuaje","raw_affiliation_strings":["Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071147116","display_name":"Rosa Mar\u00eda L\u00f3pez","orcid":"https://orcid.org/0000-0002-8450-6986","observed_orcids":["https://orcid.org/0000-0002-8450-6986"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Rosa M Lopez","raw_affiliation_strings":["Department of Pharmacy, Hospital Universitari Vall d'Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Hospital Universitari Vall d'Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111568958","display_name":"Marjorie Diaz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Marjorie Diaz","raw_affiliation_strings":["Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011596827","display_name":"Mar\u00eda Feijoo-Cid","orcid":"https://orcid.org/0000-0002-7010-373X","observed_orcids":["https://orcid.org/0000-0002-7010-373X"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Maria Feijoo","raw_affiliation_strings":["Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113603967","display_name":"Leonor Pou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Leonor Pou","raw_affiliation_strings":["Department of Clinical Biochemistry, Hospital Universitari Vall d'Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Biochemistry, Hospital Universitari Vall d'Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111848971","display_name":"M. Crespo Casal","orcid":"https://orcid.org/0000-0001-9016-0515","observed_orcids":["https://orcid.org/0000-0001-9016-0515"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Manuel Crespo","raw_affiliation_strings":["Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007133273","display_name":"Adri\u00e1n Curran","orcid":"https://orcid.org/0000-0002-1263-0814","observed_orcids":["https://orcid.org/0000-0002-1263-0814"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Adria Curran","raw_affiliation_strings":["Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087175375","display_name":"Imma Ocan\u0303a","orcid":"https://orcid.org/0000-0003-3699-0790","observed_orcids":["https://orcid.org/0000-0003-3699-0790"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Imma Oca\u00f1a","raw_affiliation_strings":["Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108083876","display_name":"Albert Pahissa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Albert Pahissa","raw_affiliation_strings":["Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5001003748"],"corresponding_institution_ids":["https://openalex.org/I4210127641"],"apc_list":null,"apc_paid":null,"fwci":7.2111,"has_fulltext":false,"cited_by_count":48,"citation_normalized_percentile":{"value":0.97508487,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"20","issue":"8","first_page":"1131","last_page":"1139"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atazanavir","display_name":"atazanavir","score":0.9959999918937683},{"id":"https://openalex.org/keywords/lopinavir-ritonavir","display_name":"lopinavir/ritonavir","score":0.9390000104904175},{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":0.7409999966621399},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.7540000081062317},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7620000243186951},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.5709999799728394},{"id":"https://openalex.org/keywords/ritonavir-boosting","display_name":"ritonavir boosting","score":0.8370000123977661},{"id":"https://openalex.org/keywords/saquinavir","display_name":"saquinavir","score":0.8889999985694885},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.8029999732971191},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.48899999260902405},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.4099999964237213},{"id":"https://openalex.org/keywords/antiretroviral-drug-resistance","display_name":"antiretroviral resistance","score":0.43299999833106995},{"id":"https://openalex.org/keywords/hiv-1-genotyping","display_name":"HIV-1 genotyping","score":0.36800000071525574}],"concepts":[{"id":"https://openalex.org/C2778335254","wikidata":"https://www.wikidata.org/wiki/Q5137314","display_name":"Cmin","level":4,"score":0.9175577163696289},{"id":"https://openalex.org/C2777182164","wikidata":"https://www.wikidata.org/wiki/Q422585","display_name":"Lopinavir","level":5,"score":0.8908872604370117},{"id":"https://openalex.org/C2778414717","wikidata":"https://www.wikidata.org/wiki/Q423467","display_name":"Atazanavir","level":5,"score":0.8709406852722168},{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.8472001552581787},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8234462738037109},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.7441134452819824},{"id":"https://openalex.org/C2776937687","wikidata":"https://www.wikidata.org/wiki/Q422654","display_name":"Saquinavir","level":5,"score":0.6903456449508667},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6159953474998474},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6018367409706116},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5931994915008545},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5218119621276855},{"id":"https://openalex.org/C2781392899","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Lopinavir/ritonavir","level":5,"score":0.4520551562309265},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.313835084438324},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.25537359714508057},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.2233489751815796},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.2029755711555481},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.14935064315795898},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.10994324088096619}],"mesh":[{"descriptor_ui":"D000069446","descriptor_name":"Atazanavir Sulfate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D016879","descriptor_name":"Salvage Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D017211","descriptor_name":"Treatment Failure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019438","descriptor_name":"Ritonavir","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019438","descriptor_name":"Ritonavir","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D019438","descriptor_name":"Ritonavir","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061466","descriptor_name":"Lopinavir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/01.aids.0000226953.56976.ad","doi":"https://doi.org/10.1097/01.aids.0000226953.56976.ad","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.aids.0000226953.56976.ad","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},{"id":"pmid:16691064","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16691064","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS (London, England)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W81998483","https://openalex.org/W1580292692","https://openalex.org/W1968173768","https://openalex.org/W1978559947","https://openalex.org/W1982425579","https://openalex.org/W1989394100","https://openalex.org/W1998616088","https://openalex.org/W1999784741","https://openalex.org/W2001169776","https://openalex.org/W2002977614","https://openalex.org/W2003808400","https://openalex.org/W2013703413","https://openalex.org/W2022204359","https://openalex.org/W2028731404","https://openalex.org/W2030265729","https://openalex.org/W2031037568","https://openalex.org/W2040506631","https://openalex.org/W2042179102","https://openalex.org/W2045369251","https://openalex.org/W2048897812","https://openalex.org/W2050508755","https://openalex.org/W2054695085","https://openalex.org/W2061243608","https://openalex.org/W2069492610","https://openalex.org/W2078078371","https://openalex.org/W2078862756","https://openalex.org/W2088008322","https://openalex.org/W2097656057","https://openalex.org/W2102442825","https://openalex.org/W2109781017","https://openalex.org/W2111376288","https://openalex.org/W2117312836","https://openalex.org/W2120572584","https://openalex.org/W2131078908","https://openalex.org/W2140453379","https://openalex.org/W2155106983","https://openalex.org/W2162487535","https://openalex.org/W2162800322","https://openalex.org/W2319484672","https://openalex.org/W2322811126","https://openalex.org/W2415784631","https://openalex.org/W3191746761","https://openalex.org/W6716186130"],"related_works":["https://openalex.org/W2159975442","https://openalex.org/W2155162504","https://openalex.org/W2166396731","https://openalex.org/W2116210217","https://openalex.org/W2044070591","https://openalex.org/W2163693543","https://openalex.org/W2324422445","https://openalex.org/W2086356171","https://openalex.org/W1966373132","https://openalex.org/W1989595643"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"assess":[2],"the":[3,41,125],"pharmacokinetics":[4,47,79],"and":[5,12,33,66,91,117,134,146,158,175,186,225,249],"tolerability":[6,248],"of":[7,52,84,203,217,223,231],"lopinavir":[8],"(LPV),":[9],"ritonavir":[10],"(RTV)":[11],"atazanavir":[13],"(ATV)":[14],"as":[15],"a":[16],"double-boosted":[17],"protease":[18],"inhibitor":[19],"regimen":[20],"in":[21,40,110,114,183,189,199,215],"HIV-infected":[22],"adults.":[23],"METHODS:":[24],"Sixteen":[25],"patients":[26,59,70,87,240],"who":[27,60,71,88],"started":[28],"LPV/RTV":[29,62,226],"(400/100":[30,63],"mg":[31,36,64,76,94],"b.i.d.)":[32],"ATV":[34,78,90,168,177,224],"(300":[35],"q.d.)":[37,95],"were":[38,48,80,100,107,129,141,153,180],"enrolled":[39],"study":[42],"group":[43],"(arm":[44,96],"A).":[45],"LPV":[46,105,122],"compared":[49,81],"to":[50,82,236],"those":[51,83],"two":[53],"historical":[54],"groups:":[55],"arm":[56,67,111,184,190],"B,":[57],"15":[58,85],"received":[61,72,89],"b.i.d.);":[65],"C,":[68],"25":[69],"LPV/RTV/saquinavir":[73],"(SQV)":[74],"(400/100/1000":[75],"b.i.d.).":[77],"consecutive":[86],"RTV":[92],"(300/100":[93],"D).":[97],"Drug":[98],"concentrations":[99,106,230],"measured":[101],"by":[102],"HPLC.":[103],"RESULTS:":[104],"significantly":[108],"higher":[109],"A":[112,174,185],"than":[113],"arms":[115,173],"B":[116],"C.":[118],"Median":[119],"(interquartile":[120],"range)":[121],"area":[123],"under":[124],"curve":[126],"(AUC)0-12":[127],"values":[128,140,152,179],"115.7":[130],"(99.8-136.5),":[131],"85.2":[132],"(68.3-109.2)":[133],"85.1":[135],"(60.6-110.1)":[136],"microg/h/ml,":[137],"respectively.":[138,150,162],"C(max)":[139,171],"12.2":[142],"(10.7-14.5),":[143],"9.5":[144],"(6.8-13.9)":[145],"10.0":[147],"(6.9-13.6)":[148],"microg/ml,":[149,161],"C(min)":[151,178],"9.1":[154],"(7.1-10.4),":[155],"5.6":[156],"(4.7-8.2)":[157],"5.5":[159],"(4.2-7.5)":[160],"No":[163],"difference":[164],"was":[165,196,211],"observed":[166],"for":[167,239],"AUC0-24":[169],"or":[170],"between":[172],"D.":[176],"1.07":[181],"(0.61-1.79)":[182],"0.58":[187],"(0.32-0.83)":[188],"D":[191],"(P":[192],"=":[193],"0.001).":[194],"Treatment":[195],"not":[197],"discontinued":[198],"any":[200],"patient":[201],"because":[202],"adverse":[204],"effects.":[205],"At":[206],"24":[207],"weeks,":[208],"viral":[209],"load":[210],"<":[212],"50":[213],"copies/ml":[214],"13":[216],"16":[218],"patients.":[219],"CONCLUSIONS:":[220],"The":[221],"combination":[222],"provided":[227],"high":[228],"plasma":[229],"both":[232],"PI,":[233],"which":[234],"seemed":[235],"be":[237],"appropriate":[238],"with":[241],"multiple":[242],"prior":[243],"therapeutic":[244],"failures,":[245],"yielding":[246],"good":[247],"substantial":[250],"antiviral":[251],"efficacy.":[252]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}